Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
Marialuisa Moccia(Institute for Experimental Endocrinology and Oncology), Francesca Carlomagno(Institute for Experimental Endocrinology and Oncology)
Cited by 17
Related Papers
BAY 43-9006 Inhibition of Oncogenic RET Mutants
|JNCI Journal of the National Cancer Institute|2006|471
Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants
|Clinical Cancer Research|2007|73
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
|Endocrine Related Cancer|2008|40
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STING
|Scientific Reports|2025|7
Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteins
|Scientific Reports|2025|1